Search results
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British ...
Utah mom sues AstraZeneca, claiming she was left ‘permanently disabled’ in COVID vaccine trial
New York Post· 2 days agoShe claims she had signed a consent form with the manufacturer at the beginning of the trial that...
Mom suffers ‘disabling pain’ after COVID shot trial, suit says. She’s suing AstraZeneca
Miami Herald via Yahoo News· 2 days agoA Utah mother is suing AstraZeneca after she participated in a clinical trial for the company’s ...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 6 days agoHowever, there were relatively early indications that the vaccine was associated with very rare, but...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 1 day agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...
CDC unveils dashboard to track bird flu as virus spreads among dairy farms
USA Today· 3 hours agoThe CDC has released a new dashboard to track the spread of bird flu. The dashboard includes data on...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoThey are also testing the cancer vaccine in patients with lung cancer. So, is ...over year and...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 4 days agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...
Government's coercion on coronavirus vaccines 'encouraged conspiracy theories', warns former...
KNDO - KNDU Tri-Cities· 6 days agoSir Jacob Rees-Mogg has said the behaviour of the government to coerce people into having Covid-19 ...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 5 days agoNovavax retains its pipeline rights and could earn substantial royalties from Sanofi's development...